Drug facts
MoleculeDiltiazem (Cardizem)
Generics already compete: 26 makers on the market. 122 A-rated products from 25 makers substitute at the counter.
Cardizem was first approved by the FDA on 11/05/1982 under NDA 018602; the application holder is Bausch Health US LLC.
The latest NADAC for DILTIAZEM 60 MG TABLET is $0.07 per unit (as of 10/28/2026).
Holder Bausch Health US LLCApplication NDA 018602Approved 11/05/1982
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Cardizem patent listed in the Orange Book Orange Book
02Competition
- Generics
- 26 generic makers Orange Book
- First generic approved
- 11/05/1992 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Diltiazem profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.07 per unitDILTIAZEM 60 MG TABLET, mid-priced of 4 strengths, as of 10/28/2026 CMS NADAC
- Latest recall
- 03/13/2025Class II, Diltiazem Hydrochloride, Glenmark Pharmaceuticals Inc., USA FDA enforcement
04Product
- Application holder
- Bausch Health US LLC Orange Book
- Application
- NDA 018602 Orange Book
- First approved
- 11/05/1982 Orange Book
- Dosage forms
- capsule, extended release; injectable; solution; tablet; tablet, extended release
- Routes
- injection, intravenous, oral
- Other brand names
- Cardizem CDCardizem LACartia XTTiazac
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.